Research

Embr Labs and UMass Amherst Develop New Biomarker to Predict and Alleviate Menopausal Hot Flashes

A collaboration between Embr Labs, a Boston-based healthtech startup and the University of Massachusetts Amherst aims to address one of the most prevalent symptoms of menopause—hot flashes. The partnership has produced new capabilities for Embr Labs’ wearable device, Embr Wave, designed to predict and mitigate the onset of menopausal hot flashes. Enhancing Embr Wave’s Features Embr Labs initially created the Embr Wave…

Thermo Fisher Scientific Releases New Tools for Fertility Research

Thermo Fisher Scientific has launched two next-generation sequencing-based assays aimed at accelerating research in fertility and reproductive health. These tools are designed to work with the Ion Torrent Genexus Integrated Sequencer and are intended for research use only meaning they are not meant to be used in diagnostic procedures. Based in Carlsbad, California, Thermo Fisher Scientific has introduced the Ion ReproSeq PGT-A…

UCL to Launch the UK’s First Menopause Education Program

Experts at UCL have teamed up with leading women’s health charities to design a new education and support program for women across the UK experiencing menopause. The National Menopause Education and Support Programme will be led by Professor Joyce Harper (UCL EGA Institute for Women’s Health), Dr Shema Tariq (UCL Institute for Global Health) and Dr Nicky Keay (UCL Medicine). It is…

NIH Allocates $24M to Set Up Maternal Health Research Centers of Excellence in the US

Addressing the pressing concern of pregnancy-related complications and deaths in the United States, the National Institutes of Health (NIH) has granted $24M for the establishment of Maternal Health Research Centers of Excellence. This initiative is part of the NIH’s Implementing a Maternal Health and Pregnancy Outcomes Vision for Everyone (IMPROVE) project. Recent data from 2021 indicates the U.S. reported over 1,200 maternal…

COVID-19 Infections and Vaccinations Temporarily Impact Menstrual Cycle, Clue Data Study Reveals

Clue, the Berlin-based menstrual and reproductive health platform, has contributed to an international study assessing the effects of COVID-19 infections and vaccinations on menstrual cycles. The study’s insights were derived from the platform’s de-identified user data. Published in Obstetrics & Gynecology, the official journal of the American College of Obstetricians and Gynecologists, the research was led by experts from the University of…

Flo Health Survey Reveals Knowledge Gaps and Lack of Access to Credible Health Information in Post-Roe America

In the aftermath of the landmark overturning of Roe v. Wade, American women find themselves navigating a complex landscape, where access to credible women’s health information has become increasingly scarce. Assessing this troubling scenario, Flo Health has released a new report titled “Failed foundations: The women’s health crisis in post-Roe America.” The report exposes glaring knowledge gaps across sexual and menstrual health,…

“There’s an App for it”: New Research Assesses Mobile Apps Providing Abortion Information

In a world where “there’s an app for that” is more than just a slogan, navigating the plethora of health-related applications can be daunting for consumers. This is particularly true when it comes to finding accurate and reliable information about abortion. A group of researchers set out to analyze the mobile app landscape in this critical area of women’s health. Their recently…

Mirvie Receives a $4.6M Grant from the Gates Foundation to Study Preeclampsia in Sub-Saharan Africa

Mirvie, a prenatal diagnostics company has received a $4.6M grant from the Bill & Melinda Gates Foundation to support the company’s efforts to predict unexpected pregnancy complications before they happen by revealing the underlying biology of each pregnancy for women on a global scale. Specifically, the funding will help launch study sites in Cameroon, Ghana, and Zambia to understand preeclampsia among pregnant…